Optical coherence tomography (OCT) features of cystoid spaces in choroideremia (CHM).


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 05 08 2019
accepted: 05 10 2019
revised: 23 09 2019
pubmed: 28 10 2019
medline: 14 7 2020
entrez: 27 10 2019
Statut: ppublish

Résumé

To investigate the prevalence and features of cystoid spaces (CS) in patients with confirmed genetic diagnosis of choroideremia (CHM) using swept source optical coherence tomography (OCT). We retrospectively reviewed CHM patients examined at the Regional Reference Center for Hereditary Retinal Degenerations at the Eye Clinic in Florence. We took into consideration genetically confirmed CHM patients with ophthalmological and swept source optical coherence tomography (OCT) examinations. The presence/absence and location of cystoid spaces in the retina of each eye were reported. A total of 42 eyes of 21 CHM patients were included in our series. The average age of the patients was 36.5 ± 20.1 (range, 13-73 years). The average best-corrected visual acuity (BCVA) for all patients was 0.63 ± 1.00 logMar (range, 0-2,80). CS were present in 15 eyes of eight patients (8/21, 38%). In all cases, CS were located in inner nuclear layer (INL); in five eyes of three patients, CS were detected also in ganglion cell layer (GCL). CS appeared as microcistoyd abnormalities and were detected in retinal areas characterized by retinal pigment epithelium (RPE) and outer retinal layers atrophy at the transition zone. Cystoid spaces in choroideremia showed peculiar features; they are clusters of small-size extrafoveal degenerative cysts mainly located in inner nuclear layer at the transition zone where outer retinal layers and RPE are severely damaged.

Identifiants

pubmed: 31654189
doi: 10.1007/s00417-019-04508-7
pii: 10.1007/s00417-019-04508-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2655-2663

Références

Br J Ophthalmol. 2019 Feb;103(2):233-237
pubmed: 29706600
Hum Mutat. 2011 Dec;32(12):1460-9
pubmed: 21905166
Ophthalmic Genet. 2012 Jun;33(2):57-65
pubmed: 22017263
Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6033-6039
pubmed: 27820636
Prog Retin Eye Res. 2006 Jul;25(4):397-424
pubmed: 16839797
Invest Ophthalmol Vis Sci. 2006 Sep;47(9):4113-20
pubmed: 16936131
Ther Adv Ophthalmol. 2018 Dec 27;10:2515841418817490
pubmed: 30627697
Eur J Hum Genet. 2011 Oct;19(10):1074-81
pubmed: 21654732
Hum Mutat. 1997;9(2):110-7
pubmed: 9067750
Retina. 2014 May;34(5):981-8
pubmed: 24756036
Ophthalmology. 2012 Mar;119(3):596-605
pubmed: 22182799
Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):627-36
pubmed: 17219109
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1315-21
pubmed: 18385043
Jpn J Ophthalmol. 2011 Mar;55(2):169-71
pubmed: 21400066
Graefes Arch Clin Exp Ophthalmol. 2017 Nov;255(11):2099-2111
pubmed: 28752371
Ocul Immunol Inflamm. 2019;27(3):474-483
pubmed: 31184556
Ophthalmology. 2013 Aug;120(8):1592-6
pubmed: 23562166
Retina. 2012 Apr;32(4):826-33
pubmed: 21886018
Hum Genet. 2003 Aug;113(3):268-75
pubmed: 12827496
Eye (Lond). 2011 Jan;25(1):84-90
pubmed: 20966974
Hum Mol Genet. 1994 Jul;3(7):1041-6
pubmed: 7981670
Ophthalmology. 1984 Jul;91(7):873-83
pubmed: 6089068
Ophthalmology. 2017 Mar;124(3):359-373
pubmed: 27986385
Surv Ophthalmol. 2004 Sep-Oct;49(5):470-90
pubmed: 15325193
Ophthalmology. 2016 Oct;123(10):2158-65
pubmed: 27506488
Ophthalmic Genet. 2019 Jun;40(3):267-275
pubmed: 31135245
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT377-87
pubmed: 27409497
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3674-84
pubmed: 27403996
Surv Ophthalmol. 2013 Nov-Dec;58(6):560-84
pubmed: 24160730
Graefes Arch Clin Exp Ophthalmol. 2019 Jan;257(1):9-22
pubmed: 30324420
Hum Mutat. 2002 Sep;20(3):189-96
pubmed: 12203991

Auteurs

Vittoria Murro (V)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Dario Pasquale Mucciolo (DP)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy. dario.mucciolo@gmail.com.

Dario Giorgio (D)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Andrea Sodi (A)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Ilaria Passerini (I)

Department of Genetic Diagnosis, Careggi Teaching Hospital, Florence, Italy.

Giacomo Bacci (G)

Pediatric Ophthalmology Unit, Meyer Children's University Hospital, Florence, Italy.

Sara Bargiacchi (S)

Medical Genetics Unit, Meyer Children's University Hospital, Florence, Italy.

Gianni Virgili (G)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Stanislao Rizzo (S)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH